not tagged
CEL-SCI
['$cvm', 'cel-sci']
cel-sci's phase 3 data presented at esmo 2022: neoadjuvant multikine achieved groundbreaking tumor response &amp; extended overall survival in locally .. $cvm 
Run by investors, for investors.

Real-time:
PRs
Gov. contract awards
Earnings
M&As
FDA approvals
Insider trades
SEC filings
And more

Not investment advice